All News | FDA

Advertising & Promotion

Jan 7, 2022
OPDP Adds New Division
Dec 31, 2021
Oregon Sets Temporary Rules for Sales Rep Licensing
Dec 24, 2021
District Court Allows Qui Tam Suit Over Marketing Claims and Speaker Programs To Continue
Dec 17, 2021
FDA Plans To Release Final Rule on DTC Ads in September
Dec 14, 2021
House Committee Report Critiques Pharma Business, Pricing Practices
Dec 9, 2021
Allergan Settles with New York over Opioid Marketing
Dec 1, 2021
OIG Will Not Sanction Drug Maker’s Arrangement with Hospitals
Nov 22, 2021
DOJ: Orthopedic Device Development Royalties Dispute with Surgeon Evolved into Illegal Kickback Scheme
Nov 19, 2021
Oregon Sues Endo Over Opioid Marketing
Nov 18, 2021
Biden Nominates Dr. Robert Califf To Head the FDA Again as Commissioner of Food and Drugs

Good Clinical Practice

Mar 7, 2022
FDA BIMO Inspections Down 17% in FY 2021
Feb 25, 2022
FDA Provides Guidance on Screening and Exit Interviews in Clinical Trials
Feb 20, 2022
FDA Warning Letter Alleges Informed Consent, IRB Violations
Feb 15, 2022
Proposed Senate HELP Committee Pandemic Bill Includes Provisions To Modernize Trials
Feb 15, 2022
Senate Narrowly Confirms Califf as FDA Commissioner
Feb 10, 2022
Bill To Increase Trial Diversity Introduced in US House
Jan 28, 2022
Final Guidance on Patient Engagement in Device Trial Design and Conduct Little Changed from 2019 Draft Guidance
Jan 23, 2022
EU, UK Look To Revise Clinical Trial Rules
Jan 14, 2022
State Bills Focus on Clinical Research
Jan 12, 2022
Clinical Trial Site Co-Owner Pleads Guilty to Obstructing FDA Inspection by Falsely Attesting to Data

U.S. Food Labeling

Dec 10,2020
Court Refuses To Enjoin Oklahoma Plant-Based Meat Labeling Law; Plaintiffs Appeal
Nov 24,2020
House Passes Bill To Add Sesame to Regulated List of Allergens
Nov 12,2020
FDA Posts Draft Guidance on Voluntary Disclosure of Sesame as Allergen
Oct 29,2020
FDA Wants Feedback on Labeling ‘Nontraditional’ Sugars
Oct 15,2020
FDA Asks for Input on Labeling Cell-based Seafood
Sep 29,2020
AMS Announces Decision on OLPP Rule
Sep 29,2020
NOSB Will Hold Online Meeting in Late October
Sep 23,2020
FDA Extends Facts Panel Compliance Flexibility to Small Firms
Sep 17,2020
FSIS Proposes To Expand Categories of Products Eligible for Generic Label Approval
Sep 3,2020
Groups, Retailers Ask Court To Force AMS To Rework GMO Rulemaking

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.